The study included patients 65 years or older who had breast-conserving surgery for hormone receptor–positive, invasive breast cancer, and then were treated with adjuvant endocrine therapy. Eligibility criteria included tumor size up to 3 cm, excision …
http://ift.tt/eA8V8J
0 comments:
Post a Comment